J&J Executive Shuffle: New CFO, Medical Devices Chair Departs
Ticker: JNJ · Form: 8-K · Filed: Aug 26, 2024 · CIK: 200406
| Field | Detail |
|---|---|
| Company | Johnson & Johnson (JNJ) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, leadership, board-of-directors
Related Tickers: JNJ
TL;DR
J&J's CFO is changing Sept 3rd, McEvoy out as Med Devices Chair. Board adds new directors.
AI Summary
Johnson & Johnson announced on August 26, 2024, changes in its executive leadership, including the appointment of Thong Q. Nguyen as Executive Vice President, Chief Financial Officer, effective September 3, 2024. The company also reported the departure of Ashley McEvoy as Executive Vice President, Chairman of Medical Devices, and the election of new directors to its Board. These changes are part of the company's ongoing governance and operational adjustments.
Why It Matters
Changes in key executive positions like CFO and division leadership can signal shifts in financial strategy or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive changes, especially at the CFO level, can introduce uncertainty regarding future financial strategies and operational direction.
Key Players & Entities
- Johnson & Johnson (company) — Registrant
- Thong Q. Nguyen (person) — Appointed Executive Vice President, Chief Financial Officer
- September 3, 2024 (date) — Effective date for new CFO
- Ashley McEvoy (person) — Departing Executive Vice President, Chairman of Medical Devices
- August 26, 2024 (date) — Report date
FAQ
Who is the new Chief Financial Officer of Johnson & Johnson?
Thong Q. Nguyen has been appointed as the new Executive Vice President, Chief Financial Officer, effective September 3, 2024.
Who has departed from their role as Chairman of Medical Devices?
Ashley McEvoy has departed from her role as Executive Vice President, Chairman of Medical Devices.
When is the effective date for the new CFO?
The appointment of Thong Q. Nguyen as CFO is effective September 3, 2024.
What other significant changes were reported on August 26, 2024?
The filing also reports the election of new directors to Johnson & Johnson's Board.
What is the standard industrial classification for Johnson & Johnson?
Johnson & Johnson's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-08-26 16:26:20
Key Financial Figures
- $1.00 — ich registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 5.50% Note
Filing Documents
- jnj-20240826.htm (8-K) — 34KB
- exhibit991-pressreleasefas.htm (EX-99.1) — 8KB
- image_0a.jpg (GRAPHIC) — 0KB
- image_1a.jpg (GRAPHIC) — 19KB
- 0000200406-24-000079.txt ( ) — 263KB
- jnj-20240826.xsd (EX-101.SCH) — 4KB
- jnj-20240826_def.xml (EX-101.DEF) — 8KB
- jnj-20240826_lab.xml (EX-101.LAB) — 33KB
- jnj-20240826_pre.xml (EX-101.PRE) — 20KB
- jnj-20240826_htm.xml (XML) — 8KB
01 Financial statements and exhibits
Item 9.01 Financial statements and exhibits (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press Release dated August 26, 2024 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 26, 2024 JOHNSON & JOHNSON (Registrant) By: /s/ Marc Larkins Marc Larkins Corporate Secretary